Cargando…

Empowering rare disease patients through patient education: the new BehçeTalk programme

BACKGROUND: Educating patients and caregivers on their disease can improve their knowledge and promote the active involvement in the therapeutic decision-making process. Naturally, patient education programmes are critically important in rare systemic autoimmune diseases, where relevant knowledge an...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinello, D., Del Bianco, A., Manzo, A., Mosca, M., Talarico, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883708/
https://www.ncbi.nlm.nih.gov/pubmed/35220963
http://dx.doi.org/10.1186/s41927-022-00247-1
_version_ 1784660004581670912
author Marinello, D.
Del Bianco, A.
Manzo, A.
Mosca, M.
Talarico, R.
author_facet Marinello, D.
Del Bianco, A.
Manzo, A.
Mosca, M.
Talarico, R.
author_sort Marinello, D.
collection PubMed
description BACKGROUND: Educating patients and caregivers on their disease can improve their knowledge and promote the active involvement in the therapeutic decision-making process. Naturally, patient education programmes are critically important in rare systemic autoimmune diseases, where relevant knowledge and expertise still remain scattered. Behçet’s disease (BD) represents a challenging rare condition, characterized by a variable spectrum of disease profile and a relapsing course. RESULTS: Recently, BehçeTalk, an educational programme tailored for BD patients, families and caregivers with, was launched. BehçeTalk, entirely co-designed with BD patients, is offering educational on-line webinars on different aspects of the disease, as well support groups for patients and caregivers coordinated by a psychologist with specific expertise in BD. CONCLUSIONS: The therapeutical management of BD is often challenging and frequently includes off-label treatments. Considering the specificities of BD, providing a specific education on the disease to patients will lead to empower them in being part of the decision-making processes, in the self-management and in improving their quality of life. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00247-1.
format Online
Article
Text
id pubmed-8883708
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88837082022-03-07 Empowering rare disease patients through patient education: the new BehçeTalk programme Marinello, D. Del Bianco, A. Manzo, A. Mosca, M. Talarico, R. BMC Rheumatol Commentary BACKGROUND: Educating patients and caregivers on their disease can improve their knowledge and promote the active involvement in the therapeutic decision-making process. Naturally, patient education programmes are critically important in rare systemic autoimmune diseases, where relevant knowledge and expertise still remain scattered. Behçet’s disease (BD) represents a challenging rare condition, characterized by a variable spectrum of disease profile and a relapsing course. RESULTS: Recently, BehçeTalk, an educational programme tailored for BD patients, families and caregivers with, was launched. BehçeTalk, entirely co-designed with BD patients, is offering educational on-line webinars on different aspects of the disease, as well support groups for patients and caregivers coordinated by a psychologist with specific expertise in BD. CONCLUSIONS: The therapeutical management of BD is often challenging and frequently includes off-label treatments. Considering the specificities of BD, providing a specific education on the disease to patients will lead to empower them in being part of the decision-making processes, in the self-management and in improving their quality of life. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00247-1. BioMed Central 2022-02-28 /pmc/articles/PMC8883708/ /pubmed/35220963 http://dx.doi.org/10.1186/s41927-022-00247-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Marinello, D.
Del Bianco, A.
Manzo, A.
Mosca, M.
Talarico, R.
Empowering rare disease patients through patient education: the new BehçeTalk programme
title Empowering rare disease patients through patient education: the new BehçeTalk programme
title_full Empowering rare disease patients through patient education: the new BehçeTalk programme
title_fullStr Empowering rare disease patients through patient education: the new BehçeTalk programme
title_full_unstemmed Empowering rare disease patients through patient education: the new BehçeTalk programme
title_short Empowering rare disease patients through patient education: the new BehçeTalk programme
title_sort empowering rare disease patients through patient education: the new behçetalk programme
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883708/
https://www.ncbi.nlm.nih.gov/pubmed/35220963
http://dx.doi.org/10.1186/s41927-022-00247-1
work_keys_str_mv AT marinellod empoweringrarediseasepatientsthroughpatienteducationthenewbehcetalkprogramme
AT delbiancoa empoweringrarediseasepatientsthroughpatienteducationthenewbehcetalkprogramme
AT manzoa empoweringrarediseasepatientsthroughpatienteducationthenewbehcetalkprogramme
AT moscam empoweringrarediseasepatientsthroughpatienteducationthenewbehcetalkprogramme
AT talaricor empoweringrarediseasepatientsthroughpatienteducationthenewbehcetalkprogramme